Highlights for the first quarter of fiscal year 2019 compared to the first quarter fiscal year 2018 for Continuing Operations:

Sales of $20.6 million, an increase of 7.7%;

Gross Profit of $3.1 million, an increase of 160.9%;

EBITDA of $2.4 million, an increase of 1464.4%

Highlights for the first quarter of fiscal year 2019, compared to the fourth quarter fiscal year 2018 for Continuing Operations:

Sales of $20.6 million, a decrease of 8.4%;

Gross Profit of $3.1 million, an increase of 15.4%;

EBITDA of $2.4 million, an increase of 13.7%

Quarterly Financial Summary

The following analysis is performed over Sales, Gross profit, and EBITDA from Continuing Operations for the comparative periods identified unless otherwise noted.

While many factors contributed to the Company’s first quarter results, two initiatives yielded significant results. First, the Company’s cost reduction plan. This plan included reductions in labor, variable and fixed expenses, and the divestiture of select unprofitable or low margin customers. Second, the Company’s targeted sales and marketing plan. In fiscal year 2018, the Company launched a new sales and marketing plan, which included a targeted sales effort to grow our market share of aerospace and medical customers. Combined, these actions contributed to gains in Sales, Gross Profit and EBITDA, as noted below. These industries will provide better visibility and margins over the economic cycle. They also will open up a much larger total available market. With early success on receiving orders, the consolidated growth in aerospace and medical, the Company is projecting an increase of 58.1% and 6.6%, respectively, for our fiscal year 2019 revenues over our fiscal year 2018 revenues, which combined is approximately $2M of new revenues.

Fiscal first quarter 2019 Revenue was $20.6 million, compared to $19.1 million in our fiscal first quarter 2018. The increase in revenue was primarily driven by higher metal injection molding (“MIM”) and plastics sales, which was due to the combination of higher sales with higher order volumes in the aerospace, medical and firearms and defense markets.

Fiscal first quarter 2019 Gross Profit was $3.1 million, compared to a gross profit of $1.2 million in our fiscal first quarter 2018. This increase was primarily the result of the cost reduction initiatives that were completed during fiscal year 2018 and the continued diversification into higher margin aerospace and medical parts sales. The effectiveness of the cost reduction initiatives can be seen from both the Precision Components Group and Stamping Group, as sales increased by approximately $1.5 million in fiscal first quarter 2019 over fiscal first quarter 2018; however, Gross profit increased by approximately $1.9 million over the same periods. Contributing to the increase in gross profit was an adjustment decreasing cost of sale by $1.0 million for an out-of-period adjustment identified during fiscal first quarter 2019 and recorded in the same period.

EBITDA was $2.4 million in the fiscal first quarter 2019 compared to $0.2 million in the fiscal first quarter 2018. Like Gross Profit, EBITDA was positively impacted by the increased revenues, aerospace and medical part profit margins, and lower costs.

Fiscal first quarter 2019 Revenue was $20.6 million, compared to $22.5 million in the fiscal fourth quarter 2018. The decrease in revenue was primarily seasonal, following historical patterns where our fiscal first quarter of a new fiscal year has lower sales volumes than our fiscal fourth quarter of the prior year. Despite the seasonal fluctuation, the strong customer orders noted in fiscal fourth quarter 2018, carried over into fiscal first quarter 2019, and are anticipated to continue in fiscal second quarter 2019 based upon customer forecasts.

Gross Profit was $3.1 million in the fiscal first quarter, compared to $2.7 million in the fiscal fourth quarter 2018. Additionally, Precision Components operating income was $0.9 million for the fiscal first quarter 2019, compared to operating loss of ($0.2) million for fiscal fourth quarter 2018. This improvement is related to the cost reduction initiatives referred to above and the continued diversification into aerospace and medical. Stamping operations are not accurately comparable in these periods due to the seasonality in their customer base, and to most of their customer base taking no shipments due to a one to two-week annual shutdown.

EBITDA was $2.4 million in the fiscal fourth quarter compared to $2.2 million in the fiscal fourth quarter 2018. EBITDA was positively impacted by lower costs from the 2018 cost reduction initiative and the continued diversification into aerospace and medical.

Further, the Company’s planned sale of 3D Material Technologies (“3DMT”) has been progressing as expected. Management presentations have begun to the interested parties and will continue throughout November. Based on current projections, we expect that we will be able to sell 3DMT prior to the end of third-quarter fiscal year 2019 with the funds being used to pay down debt. For the fiscal first quarter 2019, 3DMT had EBITDA loss of ($0.5) million.

ARC’s CEO, Alan Quasha, commented, “I am pleased that the Company continues on its path to increased profitability, particularly as compared to the prior year. We expect this trend to continue. Our first quarter of fiscal year 2019 has vastly improved over our first quarter of fiscal 2018, with sales up $1.5 million and Gross Profit and EBITDA up approximately $2 million. We have been able to grow in an efficient and targeted manner while improving our bottom line. Regarding our quarter one of fiscal 2019 compared to our quarter four of fiscal 2018, again we see the FY 2018 $9.8 million cost reduction plan paying off, despite the seasonality of sales. Gross Profit and EBITDA of our first quarter fiscal 2019 both improved and were in excess of our fiscal quarter four of 2018, despite an approximately $2 million seasonal decline in sales. This clearly highlights the hard work the Company has done to reduce expenses and continue to diversify our customer base.”

Mr. Quasha continued, “The previous shift in internal goals will continue to focus our core divisions on making sound business decisions that lead to profitable growth for our future. The quarterly results demonstrate progress towards these goals, and illustrate how we are driving the Company forward.”

GAAP to Non-GAAP Reconciliation

The Company has provided non-GAAP financial information to provide additional, meaningful comparisons of current results to prior periods’ results by excluding items that the Company does not believe are representative or indicative of its results of operations. Non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles in the United States. The Company’s non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with the Company’s consolidated financial statements prepared in accordance with GAAP. Specifically, EBITDA from Continuing Operations, EBITDA Margin from Continuing Operations, Facility EBITDA from Continuing Operations, Facility EBITDA Margin from Continuing Operations, Adjusted Earnings, and Adjusted Earnings Per Share are non-GAAP financial measures. EBITDA Margin from Continuing Operations and Facility EBITDA Margin from Continuing Operations are calculated by dividing EBITDA from Continuing Operations and Facility EBITDA from Continuing Operations, respectively, by sales.

The reconciliation to GAAP is as follows (dollars in thousands):

September 30

October 1

For the three months ended:

2018

2017

Net Loss

$

(1,696

)

$

(3,555

)

Interest Expense, Net

931

976

Income Taxes

35

172

Depreciation and Amortization

2,446

2,516

Adjustment to Exclude Loss (Gain) from Discontinued Operations

732

247

EBITDA from Continuing Operations

$

2,448

$

356

EBITDA Margin from Continuing Operations

11.9

%

1.9

%

Corporate Expenses

833

1,086

Facility EBITDA from Continuing Operations

$

3,281

$

1,442

Facility EBITDA Margin from Continuing Operations

16.0

%

7.6

%

Net Loss

$

(1,696

)

$

(3,555

)

Adjustment to Exclude Loss from Discontinued Operations, Net of Tax

732

247

Adjusted Earnings

$

(964

)

$

(3,308

)

Adjusted Earnings Per Share

$

(0.04

)

$

(0.18

)

Weighted Average Common Shares Outstanding

23,336,610

18,194,091

EBITDA from Continuing Operations excludes interest expense, net and income taxes as these items are associated with our capitalization and tax structures. EBITDA from Continuing Operations also excludes depreciation and amortization expense as these non-cash expenses reflect the impact of prior capital expenditure decisions, which may not be indicative of future capital expenditure requirements. EBITDA from Continuing Operations excludes the (income) or loss associated with discontinued operations.

Facility EBITDA from Continuing Operations consists of EBITDA from our operating segments, which excludes Corporate Expenses. We believe this is a meaningful measurement of the operating performance of our manufacturing facilities. Corporate Expenses primarily consist of costs not allocated to our manufacturing facilities, such as compensation related costs for employees assigned to corporate, board of directors’ fees and expenses, professional fees, insurance costs, and marketing costs.

Adjusted Earnings removes the impact of reorganization/transaction related expenses and the impact of discontinued operations. Reorganization expenses are primarily labor and labor related costs associated with the termination of employees. Transaction expenses are primarily professional fees related to the refinancing of debt and the sale of non-core assets.

About ARC Group WorldwideARC Group Worldwide, Inc. is a global advanced manufacturing provider focused on accelerating speed to market for its customers. ARC provides a holistic set of precision manufacturing solutions, from design and prototyping through full run production. These solutions include metal injection molding, metal 3D printing, metal stamping, plastic injection molding, clean room injection molding, thixomolding, and rapid and conformal tooling. Further, ARC utilizes technology to improve automation in manufacturing through robotics, software and process automation, and lean manufacturing to improve efficiency.

Forward Looking StatementsThis press release may contain "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995, which are based on ARC's current expectations, estimates, and projections about future events. These include, but are not limited to, statements, if any, regarding business plans, pro-forma statements, and financial projections, including ARC's ability to expand its services and realize growth. These statements are not historical facts or guarantees of future performance, events, or results. Such statements involve potential risks and uncertainties, and the general effects of financial, economic, and regulatory conditions affecting our industries. Accordingly, actual results may differ materially. ARC does not have any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For further information on risks and uncertainties that could affect ARC’s business, financial condition and results of operations, readers are encouraged to review Item 1A. – Risk Factors and all other disclosures appearing in ARC’s Form 10-K for the fiscal year ended June 30, 2018, as well as other documents ARC files from time to time with the Securities and Exchange Commission.